Last Updated: November 13, 2026

IMITREX STATDOSE (AUTOINJECTOR) Drug Patent Profile

When do Imitrex Statdose (autoinjector) patents expire, and when can generic versions of Imitrex Statdose (autoinjector) launch?

Imitrex Statdose (autoinjector) is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in IMITREX STATDOSE (AUTOINJECTOR) is sumatriptan succinate. Thirty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Imitrex Statdose (autoinjector)

A generic version of IMITREX STATDOSE (AUTOINJECTOR) was approved as sumatriptan succinate by HIKMA on February 6^th, 2009.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for IMITREX STATDOSE (AUTOINJECTOR)?
What are the global sales for IMITREX STATDOSE (AUTOINJECTOR)?
What is Average Wholesale Price for IMITREX STATDOSE (AUTOINJECTOR)?

Summary for IMITREX STATDOSE (AUTOINJECTOR)

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for IMITREX STATDOSE (AUTOINJECTOR)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	IMITREX STATDOSE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	020080-002	Feb 1, 2006	AB	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glaxosmithkline	IMITREX STATDOSE (AUTOINJECTOR)	sumatriptan succinate	SOLUTION;SUBCUTANEOUS	020080-003	Dec 23, 1996	AB	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for IMITREX STATDOSE (AUTOINJECTOR)

See the table below for patents covering IMITREX STATDOSE (AUTOINJECTOR) around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	381933		⤷ Start Trial
Austria	A208483		⤷ Start Trial
Australia	1544183		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.